Spyre Therapeutics Income Statement (2015-2025) | SYRE

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 3.43M1.07M1.58M0.86M1.37M1.15M1.25M0.98M1.48M1.26M1.48M1.51M2.38M12.00M12.00M3.64M1.36M0.62M0.17M0.17M0.20M0.69M
Operating items
Research & Development 1.62M2.74M3.13M3.97M3.60M4.42M5.38M4.74M4.95M5.83M6.24M5.79M6.87M9.12M8.93M11.80M14.39M14.81M17.84M17.57M14.56M12.45M15.76M11.86M13.58M14.85M16.78M16.98M15.37M11.98M14.25M13.78M17.39M24.66M33.68M34.93M32.64M44.74M50.48M41.62M40.15M45.25M
Selling, General & Administrative 0.85M2.12M1.36M1.62M1.83M2.45M2.06M2.05M2.36M2.36M3.02M2.32M2.88M2.93M3.31M3.51M3.27M3.82M4.31M4.34M4.46M5.67M7.02M6.35M6.82M6.84M7.30M8.82M7.67M6.95M5.08M5.23M12.06M8.58M14.07M12.85M11.51M10.65M10.77M11.94M11.79M11.64M
Other Operating Expenses 130.49M14.61M1.84M-10.00M
Operating Expenses 2.47M4.86M4.49M5.58M5.43M6.87M7.45M6.79M7.31M8.20M9.26M8.11M9.76M12.05M12.24M15.30M17.66M18.62M22.15M21.91M19.02M18.12M22.78M18.21M20.40M21.69M24.09M25.80M23.05M18.93M19.33M19.00M159.93M18.34M45.91M47.77M44.15M55.39M61.25M53.57M41.94M56.89M
Operating Income -2.47M-1.43M-3.42M-4.00M-4.57M-5.50M-6.30M-5.54M-6.33M-6.72M-8.00M-6.63M-8.24M-9.67M-12.24M-15.30M-17.66M-18.62M-22.15M-21.91M-19.02M-18.12M-22.78M-18.21M-6.71M-20.29M-20.44M-24.44M-22.42M-18.75M-19.16M-18.81M-159.25M-18.34M-45.91M-47.77M-44.15M-55.39M-61.25M-53.57M-41.94M-56.89M
EBIT -2.47M-1.43M-3.42M-4.00M-4.57M-5.50M-6.30M-5.54M-6.33M-6.72M-8.00M-6.63M-8.24M-9.67M-12.24M-15.30M-17.66M-18.62M-22.15M-21.91M-19.02M-18.12M-22.78M-18.21M-6.71M-20.29M-20.44M-24.44M-22.42M-18.75M-19.16M-18.81M-159.25M-18.34M-45.91M-47.77M-44.15M-55.39M-61.25M-53.57M-41.94M-56.89M
Non-operating items
Non Operating Investment Income -25.40M-0.93M-0.80M
Interest & Investment Income 0.00M0.01M0.01M0.01M0.03M0.07M0.07M0.07M0.10M0.10M0.14M0.15M0.14M0.26M0.34M0.43M0.51M0.62M0.58M0.43M0.30M0.09M0.04M0.02M0.02M0.04M0.03M0.04M0.10M0.29M0.41M0.42M0.35M1.25M4.13M4.43M5.92M5.18M5.78M6.49M5.87M5.38M
Other Non Operating Income -0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.02M-0.02M-0.02M-0.01M-0.02M-0.01M0.00M0.02M-0.03M-0.05M-0.02M-0.01M-0.03M0.01M0.02M-0.03M-0.07M-0.01M2.34M-21.39M-0.48M-0.61M-18.80M-0.82M2.29M-0.66M40.33M
Non Operating Income 0.00M0.01M0.00M0.01M0.02M0.07M0.06M0.06M0.08M0.09M0.12M0.14M0.13M0.26M0.33M0.41M0.49M0.60M0.57M0.41M0.29M0.09M0.06M-0.03M-0.05M-0.02M-0.01M-0.03M0.11M0.31M0.38M0.35M-57.83M-21.77M-17.27M3.95M5.31M-18.80M-0.82M8.78M5.22M45.70M
Net income details
EBT -2.47M-1.43M-3.41M-3.99M-4.54M-5.42M-6.23M-5.47M-6.24M-6.62M-7.86M-6.48M-8.10M-9.41M-11.90M-14.88M-17.15M-18.00M-21.56M-21.48M-18.73M-18.03M-22.71M-18.19M-18.22M-20.28M-20.42M-24.44M-22.31M-18.44M-18.78M-18.46M-217.07M-40.10M-63.18M-43.83M-38.84M-69.01M-56.30M-44.79M-36.72M-11.18M
Tax Provisions 0.03M0.02M0.01M-0.21M0.04M-0.04M0.01M0.00M0.03M0.02M0.00M-0.01M
Profit After Tax -2.47M-1.43M-3.41M-3.99M-4.55M-5.43M-6.24M-5.48M-6.25M-6.63M-7.87M-6.48M-8.12M-9.41M-11.92M-14.90M-17.17M-18.02M-21.57M-21.50M-18.73M-18.03M-22.71M-18.22M-6.83M-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M
Income from Continuing Operations -2.47M-1.43M-3.41M-3.99M-4.54M-5.42M-6.23M-5.47M-6.24M-6.62M-7.86M-6.48M-8.10M-9.41M-11.90M-14.88M-17.15M-18.00M-21.56M-21.48M-18.73M-18.03M-22.71M-18.19M-18.22M-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M
Consolidated Net Income -2.47M-1.43M-3.41M-3.99M-4.54M-5.42M-6.23M-5.47M-6.24M-6.62M-7.86M-6.48M-8.10M-9.41M-11.90M-14.88M-17.15M-18.00M-21.56M-21.48M-18.73M-18.03M-22.71M-18.19M-18.22M-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M
Income towards Parent Company -2.47M-1.43M-3.41M-3.99M-4.54M-5.42M-6.23M-5.47M-6.24M-6.62M-7.86M-6.48M-8.10M-9.41M-11.90M-14.88M-17.15M-18.00M-21.56M-21.48M-18.73M-18.03M-22.71M-18.19M-18.22M-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M
Preferred Dividend Payments 0.23M
Net Income towards Common Stockholders -2.70M-1.43M-3.41M-3.99M-4.55M-5.43M-6.24M-5.48M-6.24M-6.62M-7.86M-6.48M-8.10M-9.41M-11.90M-14.88M-17.15M-18.00M-21.56M-21.48M-18.73M-18.03M-22.71M-18.19M-18.22M-20.31M-20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.11M-63.18M-43.86M-38.84M-69.03M-56.30M-44.77M-36.72M-11.18M
Additional items
EPS (Basic) -4.71-2.44-5.57-6.36-7.10-0.46-0.47-0.41-0.47-0.47-0.48-0.39-0.49-0.46-0.54-0.62-0.59-0.55-0.66-0.65-0.53-0.29-0.35-0.28-0.10-0.31-24.33-0.37-0.27-4.84-4.69-4.8940.140.86-564.94-28.93-23.61-42.24-31.53-23.95-19.62-5.97
EPS (Weighted Average and Diluted) -0.43-0.28-0.31-24.33-0.37-0.27-4.84-4.69-4.8940.140.86-564.94-28.93-23.61-42.24-31.53-23.9522.86-0.15
Shares Outstanding (Weighted Average) 0.46M0.46M0.54M0.54M0.54M0.54M0.54M0.66M0.67M0.67M0.87M0.88M0.96M1.15M1.15M1.16M1.16M1.16M1.78M1.78M1.92M1.92M1.96M1.96M1.97M1.97M2.02M2.45M2.46M2.62M2.62M4.05M4.05M36.15M40.28M50.79M51.43M60.35M60.40M60.40M
Shares Outstanding (Diluted Average) 53.37M65.63M65.79M2.63M66.00M82.21M3.77M3.37M3.77M3.82M4.29M6.90M36.51M45.32M50.89M47.03M60.27M60.33M60.41M
EBITDA -2.47M-1.43M-3.42M-4.00M-4.57M-5.50M-6.30M-5.54M-6.33M-6.72M-8.00M-6.63M-8.24M-9.67M-12.24M-15.30M-17.66M-18.62M-22.15M-21.91M-19.02M-18.12M-22.78M-18.21M-6.71M-20.29M-20.44M-24.44M-22.42M-18.75M-19.16M-18.81M-159.25M-18.34M-45.91M-47.77M-44.15M-55.39M-61.25M-53.57M-41.94M-56.89M
Shares Outstanding 0.76M13.43M16.67M16.81M21.91M22.10M24.14M28.84M28.85M28.92M29.08M29.15M44.60M44.69M47.96M49.02M49.03M49.31M1.97M1.98M2.45M2.46M2.61M2.62M3.24M4.05M36.06M36.63M50.78M51.40M
Tax Rate 1.130.200.03